
jayesh warade
Scientist, content creator
less
Related Authors
Robert Hills
Cardiff University
Vivekanand Jha
Fortis Escorts Heart Institute
Maria-Corina Serban
University Of Medicine And Pharmacy Timisoara
KANNAN M
Central council for research in Siddha/Siddha Central Research Institute
Dasofunjo Kayode
Cross River University of Technology
Kelly G . Wilson
University of Mississippi
Vishnu Kumar
Dr. Ram Manohar Lohiya Avadh University Faizabad
Kendall Houk
University of California, Los Angeles
Albert Rizvanov
Kazan Federal University
Ludwig Kappos
University of Basel, University Hospital
Uploads
Papers by jayesh warade
Laboratories offer use of biochemical tests on body fluids that are clinically relevant Body fluid biochemical tests provide valuable diagnostic information, guiding healthcare providers in making accurate diagnoses, monitoring disease progression, and evaluating treatment responses. Validating tests for off label use for unconventional fluids in chemistry poses challenges and requires thorough planning. Existing research on this topic offers partial guidance for clinical labs to create their own validations. This study aims to fill some of these gaps by providing evidences for performance specification using in house validation of these assays.
Methods
Unconventional types of body fluid were use such as pleural fluid, ascetic fluid (for glucose, albumin, protein, LDH, amylase, lipase, triglyceride, urea, creatinine, bilirubin total, cholesterol, ADA) where as cerebrospinal fluid was used for (albumin, LDH, ADA). A validation protocol was used to validate each analytical method for accuracy precision, linearity, sensitivity, specificity and interfering substances along with their acceptance criteria. Alternative calibrators having fixed assigned value were use to validated recovery. The equipment used was Beckman Coulter DxC 700 AU. Statistical analysis was done using Microsoft Excel (Version 2019, Microsoft, Seattle, WA)
Results
Precision for each assay and body fluid type had a CV <9%. Recovery for the various analytes in all fluid types was 93.5-108.6%. Biorad EQAS samples results comparisons were within 95.8 – 104.2%. Serial dilution with serum samples showed specificity of >95%. Sensitivity using specimen at lower limit of detection was confirmed with precision of less than 15% of CV. There were no interferences found for icterus, lipemia and haemolysis using spiked samples. The tests assays for various body fluids were found linear till the higher measurement range with and without dilutions
Conclusions
Beckman Coulter DxC 700 AU is validated for the off label use of biochemical analysis of various body fluids.
Objectives:
The study aims to:
• Analyze the mineral composition of renal stones using FTIR spectroscopy.
• Classify the mineral components of renal stones.
• Study the trends and morphological characteristics of stones.
Methods: This cross-sectional study analyzed 3,789 renal stones received from August 2019 to May 2024. The stones were prepared and analyzed using the Agilent Cary 630 FTIR Analyzer. Data on mineral composition and morphology were collected and processed to identify various mineral trends and stone compositions.
Results: Demographics: 76.3% of stones were from male patients, with the highest incidence in the 31–40 age-group.
Composition: 93.5% of stones were of mixed composition, with calcium oxalate monohydrate being the most prevalent (38.3%).
Rare compositions: Stones with rare compositions, such as xanthine and 2, 8-dihydroxyadenine, were identified, providing insight into specific metabolic disorders.
Conclusion: Fourier transform infrared spectroscopy provides reliable results for stone composition, enabling effective and individualized treatment plans. The predominance of mixed stones underscores the need for multifactorial treatment approaches addressing dietary, metabolic, and infectious factors. Further research, particularly using advanced techniques like genetic testing, may enhance understanding of stone formation.
Keywords: Calcium oxalate, Fourier transform infrared spectroscopy, Nephrolithiasis, Renal stones, Stone composition, Urinary tract stones.
Laboratories offer use of biochemical tests on body fluids that are clinically relevant Body fluid biochemical tests provide valuable diagnostic information, guiding healthcare providers in making accurate diagnoses, monitoring disease progression, and evaluating treatment responses. Validating tests for off label use for unconventional fluids in chemistry poses challenges and requires thorough planning. Existing research on this topic offers partial guidance for clinical labs to create their own validations. This study aims to fill some of these gaps by providing evidences for performance specification using in house validation of these assays.
Methods
Unconventional types of body fluid were use such as pleural fluid, ascetic fluid (for glucose, albumin, protein, LDH, amylase, lipase, triglyceride, urea, creatinine, bilirubin total, cholesterol, ADA) where as cerebrospinal fluid was used for (albumin, LDH, ADA). A validation protocol was used to validate each analytical method for accuracy precision, linearity, sensitivity, specificity and interfering substances along with their acceptance criteria. Alternative calibrators having fixed assigned value were use to validated recovery. The equipment used was Beckman Coulter DxC 700 AU. Statistical analysis was done using Microsoft Excel (Version 2019, Microsoft, Seattle, WA)
Results
Precision for each assay and body fluid type had a CV <9%. Recovery for the various analytes in all fluid types was 93.5-108.6%. Biorad EQAS samples results comparisons were within 95.8 – 104.2%. Serial dilution with serum samples showed specificity of >95%. Sensitivity using specimen at lower limit of detection was confirmed with precision of less than 15% of CV. There were no interferences found for icterus, lipemia and haemolysis using spiked samples. The tests assays for various body fluids were found linear till the higher measurement range with and without dilutions
Conclusions
Beckman Coulter DxC 700 AU is validated for the off label use of biochemical analysis of various body fluids.
Objectives:
The study aims to:
• Analyze the mineral composition of renal stones using FTIR spectroscopy.
• Classify the mineral components of renal stones.
• Study the trends and morphological characteristics of stones.
Methods: This cross-sectional study analyzed 3,789 renal stones received from August 2019 to May 2024. The stones were prepared and analyzed using the Agilent Cary 630 FTIR Analyzer. Data on mineral composition and morphology were collected and processed to identify various mineral trends and stone compositions.
Results: Demographics: 76.3% of stones were from male patients, with the highest incidence in the 31–40 age-group.
Composition: 93.5% of stones were of mixed composition, with calcium oxalate monohydrate being the most prevalent (38.3%).
Rare compositions: Stones with rare compositions, such as xanthine and 2, 8-dihydroxyadenine, were identified, providing insight into specific metabolic disorders.
Conclusion: Fourier transform infrared spectroscopy provides reliable results for stone composition, enabling effective and individualized treatment plans. The predominance of mixed stones underscores the need for multifactorial treatment approaches addressing dietary, metabolic, and infectious factors. Further research, particularly using advanced techniques like genetic testing, may enhance understanding of stone formation.
Keywords: Calcium oxalate, Fourier transform infrared spectroscopy, Nephrolithiasis, Renal stones, Stone composition, Urinary tract stones.
Brief methodology: This prospective study included 17 patients of parathyroid adenoma, 2 blood samples were taken from patients undergoing parathyroidectomy. Among the samples, one were pre-excision, one samples were taken at 10 min after the excision of the parathyroid glands. The criterion for evaluation of results in primary hyperparathyroidism is based on a cut off of 50% of the decrease of PTH in plasma levels, while the evaluation of the results in secondary hyperparathyroidism is based on a cut off of 70% of the decrease of PTH levels in plasma after 10 min from the resection of the last gland. Serum PTH levels were analyzed.
Summary of Results: The mean pre-excision PTH level was 201.5 ± 18.5 pg/mL. At and 10-minute post tumour resection, PTH levels were 42.7 ± 2.3 pg/mL. In all cases, IOPTH levels fell by at least 50% after removing all suspected abnormal glands. All patients had a successful return to normocalcemia after surgery
Conclusions: The interaoperative intact PTH estimation in patient of undergoing parathyroidectomy has significant clinical impact and helps surgeons to assess success of parathyroidectomy in real time, minimizing complications, customizing surgical extent, higher success rates, shorter hospital stays, reduced recurrence, and improved patient outcomes.
Methods: This is a retrospective observational study. The measurement system stability of AU 700 was evaluated with respect to reagents on board stability, calibration frequency, and scheduled maintenance using sigma matrix calculation using internal quality control performance for over a period of six months. (May 2023 to Oct 2023). Data is collected for reagents contamination, reagent evaporation, carryover, cuvette blank absorption, syringe pressure, calibration recovery, equipment breakdown and daily internal quality control.
Results: The study shows the stability of 99.89% on sigma scale above industry standard (> 4.5 sigma) for AU 700 measurement system during the study period. This includes 0.75% reagent evaporation, 0.95 % carryover, 1.7% outlier in cuvette blank absorption, 0.7% outlier in calibration recovery, 0.25% outlier in syringe pressure and 6.25% outlier at 99.87% confidence interval (4.5 sigma) with 0% reagent contamination and equipment downtime.
Conclusions: Beckman Coulter AU 700 Measurement System delivers a very strong stable performance on sigma scale above industry standard (> 4.5 sigma) in a large size laboratory performing over 7000 tests per day. The results generated are precise and can be reliably consumed for clinical decision making. This data can also help in planning of quality control plan with less frequent IQCs and reducing the overall burden of cost spent on internal quality control.